feed,title,long_url,short_url
SeekingAlpha,Foghorn stock slumps 18% as FDA places full clinical hold on blood cancer trial of FHD-286,https://seekingalpha.com/news/3875730,
SeekingAlpha,"Dole Non-GAAP EPS of $0.44 beats by $0.08, revenue of $2.36B misses by $20M; lowers FY guidance",https://seekingalpha.com/news/3875729,
